Quality of life of type 1 neurofibromatosis patients: a scoping review protocol
HTML
HTML (Português (Brasil))
PDF
PDF (Português (Brasil))
EPUB
EPUB (Português (Brasil))

Keywords

Qualidade de Vida
Neurofibromatose 1
Revisão Quality of Life
Neurofibromatosis 1
Review

PlumX Metrics

Abstract

Objective: To map concepts, findings, and limitations related to quality of life in children, adolescents, and young adults with neurofibromatosis type 1. Method: This is a scoping review protocol based on Joanna Briggs Institute guidelines. Data searches will be conducted on platforms including PubMed/MEDLINE, EMBASE, Web of Science, Lilacs, CINAHL, Open Grey, and Google Scholar. The retrieved manuscripts will be organized using the Rayyan tool for duplicate identification and removal. Subsequently, the articles and other materials will be processed in the same tool for screening and selection of eligible studies by two independent researchers, and this entire process will be described in a flowchart adapted from the PRISMA-ScR checklist. Data extracted from eligible manuscripts will be presented in tables, figures, and flowcharts as appropriate. The data will be discussed and correlated to identify potential strengths and limitations related to the research topic.

https://doi.org/10.17665/1676-4285.20246688
HTML
HTML (Português (Brasil))
PDF
PDF (Português (Brasil))
EPUB
EPUB (Português (Brasil))

References

Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. Journal of Medical Genetics 2007;44:81-88. http://dx.doi.org/10.1136/jmg.2006.045906

Friedman, JM. Neurofibromatosis 1. 2022 Apr 21 [update of 1998 oct 2]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle. [citado 2023 Mar 26] Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK1109

Darrigo Junior LG, Bonalumi Filho A, D'Alessandro DSM, Geller M. Neurofibromatose tipo 1 na infância: revisão dos aspectos clínicos. Rev paul pediatr [Internet]. 2008Jun;26 (Rev. paul. pediatr., 2008 26(2)):176–82. https://doi.org/10.1590/S0103-05822008000200014

Accetturo M, Bartolomeo N, Stella A. In-silico Analysis of NF1 Missense Variants in ClinVar: Translating Variant Predictions into Variant Interpretation and Classification. International Journal of Molecular Sciences. 2020 Jan 22;21(3):721. http://dx.doi.org/10.3390/ijms21030721

World Health Organization. (1998). Programme on mental health: WHOQOL user manual (No. WHO/HIS/HSI Rev. 2012.03). World Health Organization [citado 2023 Fev 10]. Disponível em https://pesquisa.bvsalud.org/portal/resource/pt/who-77932

Ruidiaz-Gómez KS, Cacante-Caballero JV. Desenvolvimento histórico do conceito de Qualidade de Vida: uma revisão da literatura. Rev. cienc. cuidad. 2021;18(3): 96-109 https://doi.org/10.22463/17949831.2539

Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37(2):126–39. https://doi.org/10.1097/00005650-199902000-00003

Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil, H. Chapter 11: Scoping Reviews (2020 version). In: Aromataris E, Munn Z (Editors). JBI Manual for Evidence Synthesis, JBI, 2020. https://doi.org/10.46658/JBIMES-20-12

Andrade CG de, Costa ICP, Freire MEM, Dias TKC, França JRF de S, Costa SFG da. Scientific production about palliative care and communication in online journals: a scoping review. Rev Bras Enferm [Internet]. 2021;74(Rev. Bras. Enferm., 2021 74(2)):e20190378. https://doi.org/10.1590/0034-7167-2019-0378

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation BMJ 2015; 349:g7647 https://doi.org/10.1136/bmj.g7647

Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine. 2018 Oct;169(7):467-473. https://doi.org/10.7326/M18-0850

Souza LP, Diniz BL, Zen PRG. Quality of life of patients with neurofibromatosis type 1: scope review protocol [Internet]. OSF; 2023 [cited in 2023 jun 26]. Available from: https://osf.io/vcqdx/

Page MJ, McKenzie JE, Bossuyt PM, Bou-tron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guide- line for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71

Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, & Departamento de Ciência e Tecnologia. (2014). Diretrizes Metodológicas: Sistema GRADE-Manual de graduação da qualidade da evidência e força de recomendação para tomada de decisão em saúde. Disponível em https://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_sistema_grade.pdf Acesso em 2023 jun 24

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Array